Remove 2020 Remove Homecare Remove Medicare Remove Personal care
article thumbnail

How Home Health, Personal Care Reimbursement Guiding Addus’ M&A Strategy

Hospice News

As Addus HomeCare Corporation (NASDAQ: ADUS) sinks teeth into acquisitions, the company will be taking smaller bites when it comes to hospice deals. Addus has indicated for roughly the last year that it will orient its M&A strategy towards its home health and personal care services, with hospice becoming less of a priority.

article thumbnail

High Price Tags Pushing Addus Away from Hospice Acquisitions

Hospice News

High valuations have led Addus HomeCare (NASDAQ: ADUS) to pivot towards personal care and home health deals rather than hospice acquisitions. Hospice multiples broke records in 2020, 2021 and 2022, reaching as high as 29x. Addus began as a personal care provider in 1979. This is down from 51.6%

Hospice 245
professionals

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Queen City Hospice Expands in Rural Ohio with New Office

Hospice News

Ohio-based Queen City Hospice, an Addus Homecare (NASDAQ: ADUS) company, recently opened a new location in its home state. Queen City Hospice provides end-of-life care in six counties across the Cincinnati area in the southwest part of the state. Demographics are driving up a need for serious illness and end-of-life care in Ohio.

Homecare 245
article thumbnail

Hospice News’ Top 10 Stories of 2022

Hospice News

Centers for Medicare & Medicaid Services (CMS) developed new approaches for enforcing hospice regulations that will become effective on Jan. Centers for Medicare & Medicaid Services (CMS) developed new approaches for enforcing hospice regulations that will become effective on Jan. During late 2021 and 2022, the U.S.

2022 246
article thumbnail

5 Most Game-Changing Hospice Deals from 2022

Hospice News

billion divestiture of a 60% stake in Kindred at Home’s hospice and personal care segments to the private equity firm Clayton, Dubilier & Rice. Humana’s two Kindred at Home transactions added notches to the company’s belt as it expands its value-based care portfolio as both a provider and payer. This was Humana Inc.’s

2022 246
article thumbnail

How the 2023 Home Health Rule Could Change the Game in Hospice M&A

Hospice News

Uncertainty earlier this year around Medicare’s proposed 2023 home health payment rates led some stakeholders to expect a swerve towards hospice. Centers for Medicare & Medicaid Services (CMS) in August proposed a 4.2% aggregate cut in the home health base rate, reported Hospice News sister publication Home Health Care News.

2023 186